Abstract

Using transgenic zebrafish (fli1:egfp) that stably express enhanced green fluorescent protein (eGFP) within vascular endothelial cells, we recently developed and optimized a 384-well high-content screening (HCS) assay that enables us to screen and identify chemicals affecting cardiovascular development and function at non-teratogenic concentrations. Within this assay, automated image acquisition procedures and custom image analysis protocols are used to quantify body length, heart rate, circulation, pericardial area, and intersegmental vessel area within individual live embryos exposed from 5 to 72 hours post-fertilization. After ranking developmental toxicity data generated from the U.S. Environmental Protection Agency's (EPA's) zebrafish teratogenesis assay, we screened 26 of the most acutely toxic chemicals within EPA's ToxCast Phase-I library in concentration-response format (0.05–50 µM) using this HCS assay. Based on this screen, we identified butafenacil as a potent inducer of anemia, as exposure from 0.39 to 3.125 µM butafenacil completely abolished arterial circulation in the absence of effects on all other endpoints evaluated. Butafenacil is an herbicide that inhibits protoporphyrinogen oxidase (PPO) – an enzyme necessary for heme production in vertebrates. Using o-dianisidine staining, we then revealed that severe butafenacil-induced anemia in zebrafish was due to a complete loss of hemoglobin following exposure during early development. Therefore, six additional PPO inhibitors within the ToxCast Phase-I library were screened to determine whether anemia represents a common adverse outcome for these herbicides. Embryonic exposure to only one of these PPO inhibitors – flumioxazin – resulted in a similar phenotype as butafenacil, albeit not as severe as butafenacil. Overall, this study highlights the potential utility of this assay for (1) screening chemicals for cardiovascular toxicity and (2) prioritizing chemicals for future hypothesis-driven and mechanism-focused investigations within zebrafish and mammalian models.

Highlights

  • Baseline toxicity and chemical mode-of-action (MOA) data are lacking for the majority of chemicals currently in commerce within the United States and around the world

  • Chemical screening For this study, we first identified 31 of the most acutely toxic chemicals from the Environmental Protection Agency (EPA’s) ToxCast Phase-I chemical library (Table S1)

  • We leveraged our recently developed and optimized 384-well high-content screening (HCS) assay to screen and identify chemicals affecting cardiovascular development and function at nonteratogenic concentrations

Read more

Summary

Introduction

Baseline toxicity and chemical mode-of-action (MOA) data are lacking for the majority of chemicals currently in commerce within the United States and around the world In most cases, this uncertainty reflects the fact that conventional, animal-based toxicity tests are resource-intensive, require high animal numbers, and, due to a principal focus on apical endpoints, provide little to no information about chemical MOA. Small size, and rapid development ex utero, zebrafish are highly amenable to whole-organism imaging during embryogenesis and, as a result, high-content screening (HCS) assays for identifying and prioritizing hazardous compounds for further testing To this end, using transgenic zebrafish (fli1:egfp) that stably express enhanced green fluorescent protein (eGFP) within vascular endothelial cells, we recently developed and optimized a 384-well HCS assay that enables us to screen and identify chemicals affecting cardiovascular development and function at non-teratogenic concentrations [8]. Other HCS zebrafish assays have been developed for evaluating cardiac function or cardiovascular morphology [9,10,11], our assay incorporates both functional and morphological endpoints, provides increased initial sample sizes (32 embryos per treatment), and allows us to simultaneously test a wide range of concentrations (12 treatment groups, including one vehicle control)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call